{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:12:04Z","timestamp":1791036724226,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health Grants","doi-asserted-by":"crossref","award":["R01-AI067395-01"],"award-info":[{"award-number":["R01-AI067395-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health Grants","doi-asserted-by":"crossref","award":["R21-R022754-01"],"award-info":[{"award-number":["R21-R022754-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health Grants","doi-asserted-by":"crossref","award":["R21-I58002-01"],"award-info":[{"award-number":["R21-I58002-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health Grants","doi-asserted-by":"crossref","award":["1R41AR056169"],"award-info":[{"award-number":["1R41AR056169"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.vaccine.2011.02.036","type":"journal-article","created":{"date-parts":[[2011,2,27]],"date-time":"2011-02-27T09:05:40Z","timestamp":1298797540000},"page":"3230-3238","source":"Crossref","is-referenced-by-count":55,"title":["Passive immunoprotection targeting a secreted CAMP factor of Propionibacterium acnes as a novel immunotherapeutic for acne vulgaris"],"prefix":"10.1016","volume":"29","author":[{"given":"Pei-Feng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruaki","family":"Nakatsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2011.02.036_bib0005","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1073\/pnas.0607077104","article-title":"Molecular analysis of human forearm superficial skin bacterial biota","volume":"104","author":"Gao","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 12","key":"10.1016\/j.vaccine.2011.02.036_bib0010","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1099\/jmm.0.47268-0","article-title":"Characterization of skin microbiota in patients with atopic dermatitis and in normal subjects using 16S rRNA gene-based comprehensive analysis","volume":"56","author":"Dekio","year":"2007","journal-title":"J Med Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.02.036_bib0015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/clinids\/13.5.819","article-title":"Infections caused by Propionibacterium species","volume":"13","author":"Brook","year":"1991","journal-title":"Rev Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2011.02.036_bib0020","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/00006534-199612000-00016","article-title":"Microbial evaluation: 139 implants removed from symptomatic patients","volume":"98","author":"Ahn","year":"1996","journal-title":"Plast Reconstr Surg"},{"issue":"11","key":"10.1016\/j.vaccine.2011.02.036_bib0025","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/BF01967791","article-title":"Role of human microflora in health and disease","volume":"11","author":"Tancrede","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2011.02.036_bib0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000017868","article-title":"Propionibacterium acnes colonization in acne and nonacne","volume":"196","author":"Leyden","year":"1998","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.vaccine.2011.02.036_bib0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/AEM.35.1.62-66.1978","article-title":"Regional variations of cutaneous propionibacteria","volume":"35","author":"McGinley","year":"1978","journal-title":"Appl Environ Microbiol"},{"issue":"5931","key":"10.1016\/j.vaccine.2011.02.036_bib0040","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1171700","article-title":"Topographical and temporal diversity of the human skin microbiome","volume":"324","author":"Grice","year":"2009","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.036_bib0045","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0002-9440(10)63327-5","article-title":"Indigenous pulmonary Propionibacterium acnes primes the host in the development of sarcoid-like pulmonary granulomatosis in mice","volume":"165","author":"Nishiwaki","year":"2004","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.02.036_bib0050","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/path.1243","article-title":"In situ localization of Propionibacterium acnes DNA in lymph nodes from sarcoidosis patients by signal amplification with catalysed reporter deposition","volume":"198","author":"Yamada","year":"2002","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.02.036_bib0055","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-2133.1992.tb00679.x","article-title":"Staphylococcus aureus and intra-nasal mupirocin in patients receiving isotretinoin for acne","volume":"126","author":"Williams","year":"1992","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.vaccine.2011.02.036_bib0060","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1038\/jid.2008.117","article-title":"Antibodies elicited by inactivated Propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris","volume":"128","author":"Nakatsuji","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"5684","key":"10.1016\/j.vaccine.2011.02.036_bib0065","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1126\/science.1100330","article-title":"The complete genome sequence of Propionibacterium acnes, a commensal of human skin","volume":"305","author":"Bruggemann","year":"2004","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.vaccine.2011.02.036_bib0070","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1038\/jid.2008.221","article-title":"Acne vaccines: therapeutic option for the treatment of acne vulgaris?","volume":"128","author":"Kim","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.02.036_bib0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s007950100002","article-title":"Pathogenesis of acne","volume":"34","author":"Toyoda","year":"2001","journal-title":"Med Electron Microsc"},{"issue":"3","key":"10.1016\/j.vaccine.2011.02.036_bib0080","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2174\/1871526510808030160","article-title":"Vaccine therapy for P. acnes-associated diseases","volume":"8","author":"Nakatsuji","year":"2008","journal-title":"Infect Disord Drug Targets"},{"issue":"5","key":"10.1016\/j.vaccine.2011.02.036_bib0085","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.clindermatol.2004.03.004","article-title":"Acne sebaceous gland function","volume":"22","author":"Zouboulis","year":"2004","journal-title":"Clin Dermatol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.036_bib0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.sder.2005.03.001","article-title":"Insights in the pathogenic potential of Propionibacterium acnes from its complete genome","volume":"24","author":"Bruggemann","year":"2005","journal-title":"Semin Cutan Med Surg"},{"issue":"3","key":"10.1016\/j.vaccine.2011.02.036_bib0095","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1084\/jem.165.3.720","article-title":"Unspecific binding of group B streptococcal cocytolysin (CAMP factor) to immunoglobulins and its possible role in pathogenicity","volume":"165","author":"Jurgens","year":"1987","journal-title":"J Exp Med"},{"issue":"40","key":"10.1016\/j.vaccine.2011.02.036_bib0100","doi-asserted-by":"crossref","first-page":"38167","DOI":"10.1074\/jbc.M303544200","article-title":"Characterization of Streptococcus agalactiae CAMP factor as a pore-forming toxin","volume":"278","author":"Lang","year":"2003","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.036_bib0105","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1128\/jcm.8.2.238-241.1978","article-title":"Synergistic lysis of erythrocytes by Propionibacterium acnes","volume":"8","author":"Choudhury","year":"1978","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2011.02.036_bib0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/icb.1944.26","article-title":"A note on a lytic phenomenon shown by group B streptococci","volume":"22","author":"Christie","year":"1944","journal-title":"Aust J Exp Biol Med Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.036_bib0115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/jid.2010.319","article-title":"Staphylococcus aureus hijacks a skin commensal to intensify its virulence: immunization targeting beta-hemolysin and CAMP factor","volume":"131","author":"Lo","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"10","key":"10.1016\/j.vaccine.2011.02.036_bib0120","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1610-0387.2006.06053.x","article-title":"Systemic antibiotic therapy of acne vulgaris","volume":"4","author":"Ochsendorf","year":"2006","journal-title":"J Dtsch Dermatol Ges"},{"issue":"4511","key":"10.1016\/j.vaccine.2011.02.036_bib0125","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1126\/science.6791284","article-title":"Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound","volume":"213","author":"Slaga","year":"1981","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2011.02.036_bib0130","first-page":"344","article-title":"The utility of benzoyl peroxide in hydrophase base (Brevoxyl) in the treatment of acne vulgaris","volume":"5","author":"Weinberg","year":"2006","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.02.036_bib0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.det.2008.07.001","article-title":"A current review of topical benzoyl peroxide: new perspectives on formulation and utilization","volume":"27","author":"Tanghetti","year":"2009","journal-title":"Dermatol Clin"},{"issue":"4","key":"10.1016\/j.vaccine.2011.02.036_bib0140","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/carcin\/21.4.811","article-title":"Inhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin","volume":"21","author":"Zhao","year":"2000","journal-title":"Carcinogenesis"},{"issue":"16","key":"10.1016\/j.vaccine.2011.02.036_bib0145","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1021\/ja900852k","article-title":"Selective toxin sequestrants for the treatment of bacterial infections","volume":"131","author":"Simpson","year":"2009","journal-title":"J Am Chem Soc"},{"issue":"7","key":"10.1016\/j.vaccine.2011.02.036_bib0150","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1468-3083.2006.01671.x","article-title":"A review of the European directive for prescribing systemic isotretinoin for acne vulgaris","volume":"20","author":"Layton","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.vaccine.2011.02.036_bib0155","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/jama.292.6.726","article-title":"Treatment of acne vulgaris","volume":"292","author":"Haider","year":"2004","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.vaccine.2011.02.036_bib0160","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2133.1980.tb06557.x","article-title":"Facial follicular porphyrin fluorescence: correlation with age and density of Propionibacterium acnes","volume":"102","author":"McGinley","year":"1980","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.02.036_bib0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2133.2006.07517.x","article-title":"Temporal changes in sebum excretion and propionibacterial colonization in preadolescent children with and without acne","volume":"156","author":"Mourelatos","year":"2007","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.02.036_bib0170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1472-765X.2006.01866.x","article-title":"Propionibacterium acnes","volume":"42","author":"Perry","year":"2006","journal-title":"Lett Appl Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.036_bib0175","doi-asserted-by":"crossref","first-page":"e1551","DOI":"10.1371\/journal.pone.0001551","article-title":"Vaccination targeting a surface sialidase of P. acnes: implication for new treatment of acne vulgaris","volume":"3","author":"Nakatsuji","year":"2008","journal-title":"PLoS One"},{"issue":"5892","key":"10.1016\/j.vaccine.2011.02.036_bib0180","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.1160354","article-title":"Targeting QseC signaling and virulence for antibiotic development","volume":"321","author":"Rasko","year":"2008","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2011.02.036_bib0185","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2133.2008.08437.x","article-title":"Skin microbiota: a source of disease or defence?","volume":"158","author":"Cogen","year":"2008","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.vaccine.2011.02.036_bib0190","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/81113","article-title":"Genes, greens, and vaccines","volume":"18","author":"Ma","year":"2000","journal-title":"Nat Biotechnol"},{"issue":"8","key":"10.1016\/j.vaccine.2011.02.036_bib0195","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.phytochem.2004.03.004","article-title":"New advances in the production of edible plant vaccines: chloroplast expression of a tetanus vaccine antigen, TetC","volume":"65","author":"Tregoning","year":"2004","journal-title":"Phytochemistry"},{"issue":"11","key":"10.1016\/j.vaccine.2011.02.036_bib0200","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1360-1385(01)02123-9","article-title":"Transgenic plants for vaccine production: expectations and limitations","volume":"6","author":"Chargelegue","year":"2001","journal-title":"Trends Plant Sci"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2011.02.036_bib0205","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1016\/S0264-410X(00)00512-0","article-title":"Plant-based vaccines: unique advantages","volume":"19","author":"Streatfield","year":"2001","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2011.02.036_bib0210","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.biotechadv.2009.05.009","article-title":"Foreign protein production using plant cell and organ cultures: advantages and limitations","volume":"27","author":"Shih","year":"2009","journal-title":"Biotechnol Adv"},{"issue":"3","key":"10.1016\/j.vaccine.2011.02.036_bib0215","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.anaerobe.2009.10.009","article-title":"Propionibacterium acnes as an etiological agent of arthroplastic and osteosynthetic infections\u2014two cases with specific clinical presentation including formation of draining fistulae","volume":"16","author":"Soderquist","year":"2010","journal-title":"Anaerobe"},{"issue":"4","key":"10.1016\/j.vaccine.2011.02.036_bib0220","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF02667740","article-title":"Assaying chimeric genes in plants: the GUS gene fusion","volume":"5","author":"Jefferson","year":"1987","journal-title":"Plant Mol Biol Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2011.02.036_bib0225","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.pep.2007.08.016","article-title":"A novel immunogenic spore coat-associated protein in Bacillus anthracis: characterization via proteomics approaches and a vector-based vaccine system","volume":"57","author":"Liu","year":"2008","journal-title":"Protein Expr Purif"},{"issue":"19","key":"10.1016\/j.vaccine.2011.02.036_bib0230","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1016\/j.vaccine.2010.02.047","article-title":"Vaccination targeting surface FomA of Fusobacterium nucleatum against bacterial co-aggregation: implication for treatment of periodontal infection and halitosis","volume":"28","author":"Liu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.02.036_bib0370","series-title":"Plant molecular biology manual","first-page":"1","article-title":"Binary vectors","author":"An","year":"1988"},{"issue":"5","key":"10.1016\/j.vaccine.2011.02.036_bib0240","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s004380050604","article-title":"Silencing of transgenes introduced into leaves by agroinfiltration: a simple, rapid method for investigating sequence requirements for gene silencing","volume":"256","author":"Schob","year":"1997","journal-title":"Mol Gen Genet"},{"issue":"9","key":"10.1016\/j.vaccine.2011.02.036_bib0245","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.addr.2005.01.017","article-title":"Vaccines against the category B toxins: Staphylococcal enterotoxin B, epsilon toxin and ricin","volume":"57","author":"Mantis","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2011.02.036_bib0250","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0264-410X(02)00551-0","article-title":"A non-toxic lectin for antigen delivery of plant-based mucosal vaccines","volume":"21","author":"Medina-Bolivar","year":"2003","journal-title":"Vaccine"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2011.02.036_bib0255","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0169-409X(01)00162-4","article-title":"Nasal vaccines","volume":"51","author":"Davis","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2011.02.036_bib0260","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1467-7652.2005.00172.x","article-title":"Successful oral prime-immunization with VP60 from rabbit haemorrhagic disease virus produced in transgenic plants using different fusion strategies","volume":"4","author":"Gil","year":"2006","journal-title":"Plant Biotechnol J"},{"issue":"10","key":"10.1016\/j.vaccine.2011.02.036_bib0265","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.vaccine.2008.12.058","article-title":"A novel vaccine targeting Fusobacterium nucleatum against abscesses and halitosis","volume":"27","author":"Liu","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2011.02.036_bib0270","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000087011","article-title":"Review of the innate immune response in acne vulgaris: activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses","volume":"211","author":"Kim","year":"2005","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.vaccine.2011.02.036_bib0275","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.4049\/jimmunol.169.3.1535","article-title":"Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses","volume":"169","author":"Kim","year":"2002","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2011.02.036_bib0280","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.micinf.2006.04.001","article-title":"Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines\/chemokines in human sebocytes","volume":"8","author":"Nagy","year":"2006","journal-title":"Microbes Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2011.02.036_bib0285","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.4049\/jimmunol.166.3.2071","article-title":"Blockade of secondary lymphoid tissue chemokine exacerbates Propionibacterium acnes-induced acute lung inflammation","volume":"166","author":"Itakura","year":"2001","journal-title":"J Immunol"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2011.02.036_bib0290","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1099\/mic.0.27788-0","article-title":"CAMP factor homologues in Propionibacterium acnes: a new protein family differentially expressed by types I and II","volume":"151","author":"Valanne","year":"2005","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2011.02.036_bib0295","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1471-2180-10-230","article-title":"Proteomic identification of secreted proteins of Propionibacterium acnes","volume":"10","author":"Holland","year":"2010","journal-title":"BMC Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.02.036_bib0300","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1128\/AEM.41.5.1269-1270.1981","article-title":"Correlation of Propionibacterium acnes populations with the presence of triglycerides on nonhuman skin","volume":"41","author":"Webster","year":"1981","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.02.036_bib0305","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000096169","article-title":"Real-timereflectance confocal microscopy, a noninvasive tool for in vivo quantitative evaluation of comedolysis in the rhino mouse model","volume":"20","author":"Nakano","year":"2007","journal-title":"Skin Pharmacol Physiol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.02.036_bib0310","first-page":"27","article-title":"Impaired antibody response against T-dependent antigens in rhino mice","volume":"40","author":"Takaoki","year":"1980","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.vaccine.2011.02.036_bib0315","first-page":"1766","article-title":"Propionibacterium acnes-enhanced lens-induced granulomatous uveitis in the rat","volume":"33","author":"Semel","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2011.02.036_bib0320","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/1523-1747.ep12676801","article-title":"An overview of acne","volume":"62","author":"Kligman","year":"1974","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.02.036_bib0325","first-page":"349","article-title":"Propionibacterium acnes induces acute TNFalpha-mediated apoptosis of hepatocytes followed by inflammatory T-cell-mediated granulomatous hepatitis in mice","volume":"6","author":"Chen","year":"1999","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.vaccine.2011.02.036_bib0330","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/978-0-387-75532-8_8","article-title":"Optimization of recombinant protein expression in the chloroplasts of green algae","volume":"616","author":"Fletcher","year":"2007","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.036_bib0335","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s11033-009-9802-1","article-title":"Codon optimization of cry1Ab gene for hyper expression in plant organelles","volume":"37","author":"Jabeen","year":"2010","journal-title":"Mol Biol Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2011.02.036_bib0340","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1128\/IAI.01836-05","article-title":"Topical application of Escherichia coli-vectored vaccine as a simple method for eliciting protective immunity","volume":"74","author":"Zhang","year":"2006","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2011.02.036_bib0345","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1086\/386330","article-title":"Intranasal influenza vaccine in a working population","volume":"38","author":"Sendi","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2011.02.036_bib0350","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/CMR.13.4.602-614.2000","article-title":"Passive immunity in prevention and treatment of infectious diseases","volume":"13","author":"A Keller","year":"2000","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2011.02.036_bib0355","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4161\/hv.4.1.4778","article-title":"Antibody gene-based prophylaxis and therapy for biodefence","volume":"4","author":"Hu","year":"2008","journal-title":"Hum Vaccin"},{"issue":"8","key":"10.1016\/j.vaccine.2011.02.036_bib0360","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3201\/eid0808.010516","article-title":"Passive antibody administration (immediate immunity) as a specific defense against biological weapons","volume":"8","author":"Casadevall","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2011.02.036_bib0365","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijpharm.2008.10.008","article-title":"In vitro transdermal delivery of therapeutic antibodies using maltose microneedles","volume":"368","author":"Li","year":"2009","journal-title":"Int J Pharm"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11002490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11002490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T11:01:48Z","timestamp":1637319708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11002490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":73,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0264410X11002490"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.02.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}